SWOG clinical trial number
SWOG-9401 (NCCTG-90-46-52)

A Controlled Phase III Evaluation of 5-FU Combined with Levamisole and Leucovorin as Surgical Adjuvant Treatment Following Total Gross Resection of Metastatic Colorectal Cancer

Closed
Phase
III
Published
Abbreviated Title
A Controlled Phase III Evaluation of 5-FU Combined with Levamisole and Leucovorin as Surgical Adjuvant Treatment Following Total Gross Resection of Metastatic Colorectal Cancer
Activated
08/15/1994
Closed
09/10/1996

Publication Information Expand/Collapse

2001

Phase III trial of 5-Fluorouracil (5FU), levamisole (LEV), +/- leucovorin (LV) as adjuvant treatment (ADJ) of resected metastatic colorectal cancer (M-CRC) an NCCTG/MD Anderson/SWOG study.

RM Goldberg;R Langdon;DJ Sargent;R Pazdur;A Hantel;HS Wieand;MJ O'Connell;C Kardinal;K Rowland;J Kugler Proc of the American Society of Clinical Oncology 20:133a(#527)

1995

Phase II study of taxol in patients (pts) with recurrent malignant glioma: North American Brain Tumor Consortium

M Prados;C Schold;A Spence;M Berger;L McAllister;M Mehta;M Gilbert;D Fulton;S Chang ASCO 14:146(#281)